Selected research
Industry Research
Transfusion Diagnosis for Donor Industry Research Report 2026
Market perspective
The global Transfusion Diagnosis for Donor market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Transfusion Diagnosis for Donor market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Transfusion Diagnosis for Donor market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Transfusion Diagnosis for Donor market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Transfusion Diagnosis for Donor include Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH and Diasorin, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Transfusion Diagnosis for Donor market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Transfusion Diagnosis for Donor.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Transfusion Diagnosis for Donor Market by Company
Grifols
F. Hoffmann-La Roche
Abbott
Bio-Rad Laboratories
Werfen
QuidelOrtho Corporation
AliveDx Holdings Finance
BAG Diagnostics GmbH
Diasorin
Prestige Diagnostics
Atlas Medical GmbH
Lorne Laboratories
Transfusion Diagnosis for Donor Segment by Type
Instruments
Kits and Reagents
Transfusion Diagnosis for Donor Segment by Application
Blood Banks
Blood Donation/Transfusion Centers
Others
Transfusion Diagnosis for Donor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transfusion Diagnosis for Donor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transfusion Diagnosis for Donor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transfusion Diagnosis for Donor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Transfusion Diagnosis for Donor companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Instruments
- Kits and Reagents
Applications
- Blood Banks
- Blood Donation/Transfusion Centers
- Others
Companies covered
- Grifols
- F. Hoffmann-La Roche
- Abbott
- Bio-Rad Laboratories
- Werfen
- QuidelOrtho Corporation
- AliveDx Holdings Finance
- BAG Diagnostics GmbH
- Diasorin
- Prestige Diagnostics
- Atlas Medical GmbH
- Lorne Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Transfusion Diagnosis for Donor by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Instruments
- 2.2.3 Kits and Reagents
- 2.3 Transfusion Diagnosis for Donor by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Blood Banks
- 2.3.3 Blood Donation/Transfusion Centers
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Transfusion Diagnosis for Donor Breakdown Data by Type
- 3.1 Global Transfusion Diagnosis for Donor Historic Market Size by Type (2021-2026)
- 3.2 Global Transfusion Diagnosis for Donor Forecasted Market Size by Type (2027-2032)
4 Transfusion Diagnosis for Donor Breakdown Data by Application
- 4.1 Global Transfusion Diagnosis for Donor Historic Market Size by Application (2021-2026)
- 4.2 Global Transfusion Diagnosis for Donor Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Transfusion Diagnosis for Donor Market Perspective (2021-2032)
- 5.2 Global Transfusion Diagnosis for Donor Growth Trends by Region
- 5.2.1 Global Transfusion Diagnosis for Donor Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Transfusion Diagnosis for Donor Historic Market Size by Region (2021-2026)
- 5.2.3 Transfusion Diagnosis for Donor Forecasted Market Size by Region (2027-2032)
- 5.3 Transfusion Diagnosis for Donor Market Dynamics
- 5.3.1 Transfusion Diagnosis for Donor Industry Trends
- 5.3.2 Transfusion Diagnosis for Donor Market Drivers
- 5.3.3 Transfusion Diagnosis for Donor Market Challenges
- 5.3.4 Transfusion Diagnosis for Donor Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Transfusion Diagnosis for Donor Players by Revenue
- 6.1.1 Global Top Transfusion Diagnosis for Donor Players by Revenue (2021-2026)
- 6.1.2 Global Transfusion Diagnosis for Donor Revenue Market Share by Players (2021-2026)
- 6.2 Global Transfusion Diagnosis for Donor Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Transfusion Diagnosis for Donor Head Office and Area Served
- 6.4 Global Transfusion Diagnosis for Donor Players, Product Type & Application
- 6.5 Global Transfusion Diagnosis for Donor Manufacturers Established Date
- 6.6 Global Transfusion Diagnosis for Donor Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Transfusion Diagnosis for Donor Market Size (2021-2032)
- 7.2 North America Transfusion Diagnosis for Donor Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
- 7.4 North America Transfusion Diagnosis for Donor Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Transfusion Diagnosis for Donor Market Size (2021-2032)
- 8.2 Europe Transfusion Diagnosis for Donor Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
- 8.4 Europe Transfusion Diagnosis for Donor Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Transfusion Diagnosis for Donor Market Size (2021-2032)
- 9.2 Asia-Pacific Transfusion Diagnosis for Donor Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Transfusion Diagnosis for Donor Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Transfusion Diagnosis for Donor Market Size (2021-2032)
- 10.2 South America Transfusion Diagnosis for Donor Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
- 10.4 South America Transfusion Diagnosis for Donor Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Transfusion Diagnosis for Donor Market Size (2021-2032)
- 11.2 Middle East & Africa Transfusion Diagnosis for Donor Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Grifols
- 12.1.1 Grifols Company Information
- 12.1.2 Grifols Business Overview
- 12.1.3 Grifols Revenue in Transfusion Diagnosis for Donor Business (2021-2026)
- 12.1.4 Grifols Transfusion Diagnosis for Donor Product Portfolio
- 12.1.5 Grifols Recent Developments
- 12.2 F. Hoffmann-La Roche
- 12.2.1 F. Hoffmann-La Roche Company Information
- 12.2.2 F. Hoffmann-La Roche Business Overview
- 12.2.3 F. Hoffmann-La Roche Revenue in Transfusion Diagnosis for Donor Business (2021-2026)
- 12.2.4 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product Portfolio
- 12.2.5 F. Hoffmann-La Roche Recent Developments
- 12.3 Abbott
- 12.3.1 Abbott Company Information
- 12.3.2 Abbott Business Overview
- 12.3.3 Abbott Revenue in Transfusion Diagnosis for Donor Business (2021-2026)
- 12.3.4 Abbott Transfusion Diagnosis for Donor Product Portfolio
- 12.3.5 Abbott Recent Developments
- 12.4 Bio-Rad Laboratories
- 12.4.1 Bio-Rad Laboratories Company Information
- 12.4.2 Bio-Rad Laboratories Business Overview
- 12.4.3 Bio-Rad Laboratories Revenue in Transfusion Diagnosis for Donor Business (2021-2026)
- 12.4.4 Bio-Rad Laboratories Transfusion Diagnosis for Donor Product Portfolio
- 12.4.5 Bio-Rad Laboratories Recent Developments
- 12.5 Werfen
- 12.5.1 Werfen Company Information
- 12.5.2 Werfen Business Overview
- 12.5.3 Werfen Revenue in Transfusion Diagnosis for Donor Business (2021-2026)
- 12.5.4 Werfen Transfusion Diagnosis for Donor Product Portfolio
- 12.5.5 Werfen Recent Developments
- 12.6 QuidelOrtho Corporation
- 12.6.1 QuidelOrtho Corporation Company Information
- 12.6.2 QuidelOrtho Corporation Business Overview
- 12.6.3 QuidelOrtho Corporation Revenue in Transfusion Diagnosis for Donor Business (2021-2026)
- 12.6.4 QuidelOrtho Corporation Transfusion Diagnosis for Donor Product Portfolio
- 12.6.5 QuidelOrtho Corporation Recent Developments
- 12.7 AliveDx Holdings Finance
- 12.7.1 AliveDx Holdings Finance Company Information
- 12.7.2 AliveDx Holdings Finance Business Overview
- 12.7.3 AliveDx Holdings Finance Revenue in Transfusion Diagnosis for Donor Business (2021-2026)
- 12.7.4 AliveDx Holdings Finance Transfusion Diagnosis for Donor Product Portfolio
- 12.7.5 AliveDx Holdings Finance Recent Developments
- 12.8 BAG Diagnostics GmbH
- 12.8.1 BAG Diagnostics GmbH Company Information
- 12.8.2 BAG Diagnostics GmbH Business Overview
- 12.8.3 BAG Diagnostics GmbH Revenue in Transfusion Diagnosis for Donor Business (2021-2026)
- 12.8.4 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product Portfolio
- 12.8.5 BAG Diagnostics GmbH Recent Developments
- 12.9 Diasorin
- 12.9.1 Diasorin Company Information
- 12.9.2 Diasorin Business Overview
- 12.9.3 Diasorin Revenue in Transfusion Diagnosis for Donor Business (2021-2026)
- 12.9.4 Diasorin Transfusion Diagnosis for Donor Product Portfolio
- 12.9.5 Diasorin Recent Developments
- 12.10 Prestige Diagnostics
- 12.10.1 Prestige Diagnostics Company Information
- 12.10.2 Prestige Diagnostics Business Overview
- 12.10.3 Prestige Diagnostics Revenue in Transfusion Diagnosis for Donor Business (2021-2026)
- 12.10.4 Prestige Diagnostics Transfusion Diagnosis for Donor Product Portfolio
- 12.10.5 Prestige Diagnostics Recent Developments
- 12.11 Atlas Medical GmbH
- 12.11.1 Atlas Medical GmbH Company Information
- 12.11.2 Atlas Medical GmbH Business Overview
- 12.11.3 Atlas Medical GmbH Revenue in Transfusion Diagnosis for Donor Business (2021-2026)
- 12.11.4 Atlas Medical GmbH Transfusion Diagnosis for Donor Product Portfolio
- 12.11.5 Atlas Medical GmbH Recent Developments
- 12.12 Lorne Laboratories
- 12.12.1 Lorne Laboratories Company Information
- 12.12.2 Lorne Laboratories Business Overview
- 12.12.3 Lorne Laboratories Revenue in Transfusion Diagnosis for Donor Business (2021-2026)
- 12.12.4 Lorne Laboratories Transfusion Diagnosis for Donor Product Portfolio
- 12.12.5 Lorne Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst